ACRV
Acrivon Therapeutics, Inc. Common Stock
stockNASDAQ
acrivon therapeutics is a biotech company specializing in drug development through early clinical treatment success using our unique predictive biomarker approach. our technology platform is based on integrating drug-regulated, global proteomics with focused intact tissue digital imaging to develop drug-tailored biomarker signatures for prospective patient responder identification. the foundational science is based on proven, pathway-based methods linking active disease-driving mechanisms with the drug mechanism-of-action, to precisely match the therapy with patients who will benefit. our method is applicable across drug modalities
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.87 | 2026-10-08 | -5.35% | 1.479 |
| 1M | 1.83 | 2026-09-15 | -3.28% | 2.160 |
| 3M | 1.92 | 2026-07-15 | -7.81% | 2.142 |
| 6M | 1.67 | 2026-04-15 | +5.99% | 2.011 |
| 1Y | 1.89 | 2025-10-15 | -6.35% | 1.988 |
| 2Y | 7.60 | 2024-10-15 | -76.71% | — |
| 5Y | 16.64 | 2022-11-15 | -89.36% | 1.544 |
Acrivon Therapeutics, Inc. Common Stock (NASDAQ:ACRV) stock price today is $1.77, and today's volume is 104,454. ACRV is up 2.907% today. The 30 day average volume is 300,106. ACRV market cap is $75.85M with 42.85M shares outstanding.